Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.2233
+0.0003 (0.13%)
Aug 12, 2025, 11:53 AM - Market open
H&E Equipment Services Market Cap
Processa Pharmaceuticals has a market cap or net worth of $11.24 million as of August 12, 2025. Its market cap has increased by 136.81% in one year.
Market Cap
11.24M
Enterprise Value
4.32M
1-Year Change
136.81%
Ranking
Category
Stock Price
$0.22
Market Cap Chart
Since October 9, 2017, Processa Pharmaceuticals's market cap has decreased from $1.04B to $11.24M, a decrease of -98.92%. That is a compound annual growth rate of -43.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 11.23M | 288.87% |
| Dec 31, 2024 | 2.89M | -64.97% |
| Dec 29, 2023 | 8.24M | -53.15% |
| Dec 30, 2022 | 17.59M | -77.16% |
| Dec 31, 2021 | 77.01M | 10.52% |
| Dec 31, 2020 | 69.68M | -29.44% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |